Abstract
When compared to clinical trials involving a new (unapproved for human use) drug or biologic, utilizing an approved, commercially available medication in a clinical trial can introduce a new set of variables surrounding procurement and distribution, all of which are fundamental to successful trial implementation. Numerous procurement factors must be considered, including the identification of a suitable vendor, manufacturing of a matching placebo, and expiration dating, all of which can become more intricate when the study increases in complexity by involving factors like active comparators, drug tapering regimens, and research sites in more than one country. Distribution is a similarly complex operation, which involves adherence to regulatory requirements and consideration of aspects such as blinded study designs or utilization of additional safeguards with the use of controlled substances. This chapter will review the basic factors to be taken into consideration during the planning and operational stages of a clinical trial involving a marketed medication and provide examples of how to manage these factors, all of which are aimed at ensuring compliance with both applicable local and international laws and with guidance documents aimed at protecting the rights, safety, and well-being of trial participants.
Similar content being viewed by others
References
Choudhry N, Krumme A, Ercole P et al (2017) Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Intern Med 177(5):624–631
Dragic L, Lee E, Wertheimer A, et al. (2015) Classifications of controlled substances: insights from 23 countries. Inov Pharm 6(2):Article 201
State of California Department of Justice (2018) Research advisory panel. https://oag.ca.gov/research. Accessed 06 Sep 2018
United Nations (1961) Single convention on narcotic drugs. https://www.unodc.org/pdf/convention_1961_en.pdf. Accessed 04 Oct 2018
United Nations (1971) Convention on psychotropic substances. https://www.unodc.org/pdf/convention_1971_en.pdf. Accessed 04 Oct 2018
United Nations (1988) Convention against illicit traffic in narcotic drugs and psychotropic substances. https://www.unodc.org/pdf/convention_1988_en.pdf. Accessed 04 Oct 2018
United States Department of Justice Drug Enforcement Administration, Diversion Control Division (2018) Control substance schedules. https://www.deadiversion.usdoj.gov/schedules/. Accessed 04 Oct 2018
United States Drug Enforcement Administration (2018) Drug scheduling. https://www.dea.gov/drug-scheduling. Accessed 04 Oct 2018
US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (2017) Guidance for industry: re-packaging of certain human drug products by pharmacies and outsourcing facilities. https://www.fda.gov/downloads/Drugs/Guidances/UCM434174.pdf. Accessed 19 Oct 2018
Woodworth T (2011) How will DEA affect your clinical study? J Clin Res Best Pract 7(12):1–9
World Health Organization (WHO) (2018) Substances under international control. http://www.who.int/medicines/areas/quality_safety/sub_Int_control/en/. Accessed 06 Sep 2018
Yeung D, Alvarez K, Quinones M et al (2003) Low-health literacy flashcards & mobile video reinforcement to improve medication adherence in patients on oral diabetes, heart failure, and hypertension medications. J Am Pharm Assoc 57(1):30–27
Zhao W, Durkalski V, Pauls K et al (2010) An electronic regulatory document management system for a clinical trial network. Contemp Clin Trials 31:27–33
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Hardter, E., Collins, J., Shmueli-Blumberg, D., Armstrong, G. (2020). Procurement and Distribution of Study Medicines. In: Piantadosi, S., Meinert, C.L. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_34-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52677-5_34-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52677-5
Online ISBN: 978-3-319-52677-5
eBook Packages: Springer Reference MathematicsReference Module Computer Science and Engineering